|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q3 FY2021
As of Sep 30, 2021
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Account receivables | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Digital assets, net | ||||||||||||||||||||
| Inventories, net | ||||||||||||||||||||
| Accounts receivables | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Non-current assets: | ||||||||||||||||||||
| Deferred financing cost, net | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Construction in progress | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Right-of-use assets, net | ||||||||||||||||||||
| Total non-current assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS’ DEFICIT | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued liabilities and other payables | ||||||||||||||||||||
| Accrued consulting and service fee | ||||||||||||||||||||
| Amounts due to related parties | ||||||||||||||||||||
| Amount due to director | ||||||||||||||||||||
| Amount due to shareholder | ||||||||||||||||||||
| Construction payable | ||||||||||||||||||||
| Contract liabilities | ||||||||||||||||||||
| Convertible notes payable | ||||||||||||||||||||
| Promissory notes | ||||||||||||||||||||
| Promissory notes payable | ||||||||||||||||||||
| Earn-out payable | ||||||||||||||||||||
| Lease liabilities | ||||||||||||||||||||
| Income tax payable | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Lease liabilities | ||||||||||||||||||||
| Earn-out payable | ||||||||||||||||||||
| Total non-current liabilities | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| Commitments and contingencies (Note 17) | ||||||||||||||||||||
| Preferred stock, value | ||||||||||||||||||||
| Preferred Stock | ||||||||||||||||||||
| Series A Preferred Stock | ||||||||||||||||||||
| Series B Preferred Stock | ||||||||||||||||||||
| Series C Preferred Stock | ||||||||||||||||||||
| Common stock, par value $0.0001, 270,000,000,000 shares authorized, 390,024,555 and 362,844,342 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Shares to be issued, par value $0.0001, 0 and 15,816,576 shares to be issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Accumulated losses | ||||||||||||||||||||
| Total shareholders’ deficit | ||||||||||||||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT | ||||||||||||||||||||
Loading...
